Bernstein Harold 4
4 · Maze Therapeutics, Inc. · Filed Sep 24, 2025
Insider Transaction Report
Form 4
Bernstein Harold
President, R&D & CMO
Transactions
- Award
Restricted Stock Units
2025-09-22+40,000→ 40,000 total→ Common Stock (40,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
- [F2]The award shall vest as to 1/2 of the total award on September 1, 2026 and September 1, 2027, subject to the reporting person's continued service to the Issuer on each vesting date.
- [F3]These restricted stock units do not expire; they either vest or are cancelled prior to the vesting date.